Millions of Americans are not taking GLP-1 drugs as prescribed due to cost and access barriers
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Millions of Americans are failing to take their GLP-1 medications as prescribed. Ongoing cost and access barriers are pushing patients toward modified usage patterns and unapproved versions of the treatments to manage their health.
Continue in the app — vote & join in ➔Source: Ars Technica · via ahirlevel.hu